<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS103447</article-id>
<article-id pub-id-type="doi">10.1101/2020.10.13.336768</article-id>
<article-id pub-id-type="archive">PPR226084</article-id>
<article-version article-version-type="publisher-id">3</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of the antiviral effect of chlorine dioxide (ClO<sub>2</sub>) using a vertebrate model inoculated with avian coronavirus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zambrano-Estrada</surname>
<given-names>Xóchitl</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Domínguez-Sánchez</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Banuet-Martínez</surname>
<given-names>Marina</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guerrero de la Rosa</surname>
<given-names>Fabiola</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Gasca</surname>
<given-names>Teresa</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prieto-Valiente</surname>
<given-names>Luis</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Acevedo-Whitehouse</surname>
<given-names>Karina</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Laboratory of Veterinary Diagnostic Pathology. School of Natural Sciences. Autonomous University of Queretaro. Av. De las Ciencias S/N. Juriquilla, Queretaro. Qro. C.P.76230. Mexico</aff>
<aff id="A2">
<label>b</label>Unit for Basic and Applied Microbiology. School of Natural Sciences. Autonomous University of Queretaro. Anillo Vial Fray Junípero Serra, Querétaro, Qro. C.P. 76140, Mexico</aff>
<aff id="A3">
<label>c</label>Laboratory of Cellular Biology. School of Natural Sciences. Autonomous University of Queretaro. Av. De las Ciencias S/N. Juriquilla, Queretaro. Qro. C.P. 76230. Mexico</aff>
<aff id="A4">
<label>d</label>Bioestadística Médica y Metodología de la Investigación, Análisis Estadístico y Big Data, Universidad Católica de Murcia. Av. de los Jerónimos, 135 Guadalupe de Maciascoque Murcia, 30107. Spain</aff>
<author-notes>
<corresp id="CR1">
<bold>Corresponding author:</bold> Karina Acevedo-Whitehouse (<email>karina.acevedo.whitehouse@uaq.mx</email>)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>04</day>
<month>11</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>01</day>
<month>11</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">The need for safe and effective antiviral treatments is pressing given the number of viral infections that are prevalent in animal and human populations, often causing devastating economic losses and mortality. Informal accounts of anecdotal use of chlorine dioxide (ClO<sub>2</sub>), a well-known disinfectant and antiseptic, in COVID-19 patients has raised concern about potential toxicity, but also raises the question that ClO<sub>2</sub> might elicit antiviral effects, a possibility that has never been examined <italic>in vivo</italic> in any animal model. Here, we challenged the hypothesis that ClO<sub>2</sub> decreases the viral load and virus-induced mortality in a vertebrate model. For this, we determined viral load, virus-induced lesions and mortality in 10-day old chick embryos inoculated with 10<sup>4</sup> mean EID<sub>50</sub>/mL of attenuated Massachusetts and Connecticut avian coronavirus (IBV) strains.</p>
</sec>
<sec id="S2">
<title>Results</title>
<p id="P2">The ClO<sub>2</sub> treatment had a marked impact on IBV infection. Namely, viral titres were 2.4-fold lower and mortality was reduced by half in infected embryos that were treated with ClO<sub>2</sub>. Infection led to developmental abnormalities regardless of treatment. Lesions typical of IBV infections were observed in all inoculated embryos, but severity tended to be significantly lower in ClO<sub>2</sub>-treated embryos. We found no gross or microscopic evidence of toxicity caused by ClO<sub>2</sub> at the doses used herein.</p>
</sec>
<sec id="S3">
<title>Conclusions</title>
<p id="P3">Our study shows that ClO<sub>2</sub> could be a safe and viable way of treating and mitigating the effects of avian coronavirus infections, and raises the possibility that similar effects could be observed in other organisms.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Chlorine dioxide</kwd>
<kwd>ClO<sub>2</sub>
</kwd>
<kwd>coronavirus</kwd>
<kwd>IBV</kwd>
<kwd>antiviral</kwd>
<kwd>chick embryo</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S4" sec-type="intro">
<title>Background</title>
<p id="P4">To date, despite advances in the identification of compounds with antiviral activity, the available repertoire of antiviral drugs is insufficient. Given the number of endemic viruses that impact the health of wild and domestic animals as well as human populations the need for effective and safe antivirals is urgent. The COVID19 pandemic has evidenced this need; since its start in January 2020, a steep rise in cases and associated mortality, mounting pressure on health services worldwide, and a marked damage to the economy of most countries [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>] warrants rigorous, unbiased investigation of compounds with potential antiviral action.</p>
<p id="P5">The surge in COVID19 cases and the lack of effective treatments have led to a growing number of informal reports and testimonials across social networks regarding the oral and intravenous use of chlorine dioxide (ClO<sub>2</sub>) solution as an efficacious treatment of COVID19. In an unprecedented move, the Senate of Bolivia authorized the extraordinary use of ClO<sub>2</sub> to “manufacture, sell, supply and use ClO<sub>2</sub> to prevent and treat COVID19” (law PL N° 219/2019-2020 CS approved 15 July 2020). This situation has sparked concern from health agencies of various countries regarding the potential toxicity of using this disinfectant as a treatment, given that ClO<sub>2</sub> has strong oxidative properties. Chlorine dioxide has been known since 1946 for its broad antimicrobial properties [<xref ref-type="bibr" rid="R3">3</xref>], and it is commonly used to purify water for human consumption, decontaminate produce and other food items [<xref ref-type="bibr" rid="R4">4</xref>], and disinfect surgical instruments [<xref ref-type="bibr" rid="R5">5</xref>]. According to the Food and Drug Administration (FDA) of the US, consuming ClO<sub>2</sub> can lead to adverse effects such as ‘vomiting, diarrhoea, dehydration, abdominal pain, metahemaglobinemia and systemic failures that could potentially lead to death’. However, an impartial review of the scientific peer-reviewed literature reveals few case reports of human patients presenting adverse effects after consumption of ClO<sub>2</sub>, none of which were fatal, and reversed completely after treatment [<xref ref-type="bibr" rid="R6">6</xref>–<xref ref-type="bibr" rid="R9">9</xref>]. Published studies on ClO<sub>2</sub> toxicity have reported null to mild effects in adult humans and other animals [<xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R12">12</xref>] and have stressed that toxicity is strongly dose-dependent [<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref>].</p>
<p id="P6">There is evidence of virucidal activity of ClO<sub>2</sub> against echovirus [<xref ref-type="bibr" rid="R15">15</xref>], enterovirus [<xref ref-type="bibr" rid="R16">16</xref>], poliovirus [<xref ref-type="bibr" rid="R17">17</xref>], rotavirus [<xref ref-type="bibr" rid="R18">18</xref>], norovirus [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>], calicivirus [<xref ref-type="bibr" rid="R19">19</xref>], and coronavirus [<xref ref-type="bibr" rid="R21">21</xref>]. However, there are few publications that explore antiviral effects <italic>in vitro</italic> and <italic>in vivo</italic>. One of the few published studies found that mice exposed to influenza A virus in an environment that contained aerosolized ClO<sub>2</sub> had significantly lower mortality than mice that were solely exposed to Influenza A virus [<xref ref-type="bibr" rid="R22">22</xref>]. The authors reported that the antiviral effect was due to denaturation of hemagglutinin and neuraminidase glycoproteins, a finding that concurs with previous studies that explain the virucidal mechanism of action of ClO<sub>2</sub> due to oxidation of amino acid residues that are key for cell entry [<xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R25">25</xref>]. More recently, the antiviral mechanism of action of ClO<sub>2</sub> was investigated <italic>in vitro</italic> using pig alveolar macrophages and MARC-145 cells exposed to the porcine reproductive and respiratory syndrome virus (PRRSV1), finding that the chemical also inhibits the synthesis of pro-inflammatory molecules that contribute to the pathogenesis of this disease [<xref ref-type="bibr" rid="R26">26</xref>]. The authors concluded that viral synthesis of RNA and proteins was impeded by ClO<sub>2</sub>, leading to a reduction in viral replication. Despite these studies, to date there has been no published report of an <italic>in vivo</italic> assessment of the antiviral effect of ClO<sub>2</sub>. Here, we have investigated the effect of a ClO<sub>2</sub> solution in 10-day old chick embryos inoculated with attenuated avian infectious bronchitis coronavirus (IBV) Massachusetts and Connecticut vaccine strains, which are pathogenic for birds during their embryonic stages of development [<xref ref-type="bibr" rid="R27">27</xref>].</p>
</sec>
<sec id="S5" sec-type="results">
<title>Results</title>
<p id="P7">Avian coronavirus RNA was detected in all of the embryos that were inoculated with the vaccine (n=15, in all cases Cq &lt;40). The viral load decreased significantly with increasing ClO<sub>2</sub> (p=<bold>0.009</bold> for linear trend; <xref ref-type="fig" rid="F1">Fig. 1</xref>), doses being 2.4 times higher in the untreated embryos. The average viral load of ClO<sub>2</sub>-treated chicks was 10<sup>4.3</sup>/mL, range: 10<sup>3.66</sup> – 10<sup>5.03</sup> and of untreated chicks was 10<sup>4.83</sup>/mL, range: 10<sup>4.52</sup> – 10<sup>5.01</sup>, respectively (Tukey HSD, Group E <italic>vs</italic>. F, p = 0.03). There were no differences in the viral load between both ClO<sub>2</sub>-treated groups (p&gt;0.05).</p>
<p id="P8">Mortality differed significantly between virus-inoculated (46.7%) and virus-free embryos (6.7%) (Fisher’s exact p = 0.018), (<xref ref-type="fig" rid="F2">Fig. 2</xref>). In the viral-inoculated groups, 3/10 (30 %) embryos treated with ClO<sub>2</sub> and 4/5 (80 %) untreated embryos died (Groups D, E and F, respectively). (Fisher’s exact p = 0.119).</p>
<p id="P9">Body mass, embryonic axis length and femur length differed between the virus-inoculated and virus free-groups, regardless of ClO<sub>2</sub> treatment. All of the virus-inoculated embryos exhibited dwarfing and had, on average, 38% lower mass (t = 21.15, df = 29.40, p = 2.2 x 10<sup>-16</sup>; <xref ref-type="fig" rid="F3">Fig. 3A</xref>), 10% shorter axis length (t = 58.43, df = 29.26, p = 2.2 x 10<sup>-16</sup>; <xref ref-type="fig" rid="F3">Fig. 3B</xref>), and 20% shorter femur length (t = 8.49, df = 23.34, p = 1.4 x 10<sup>-8</sup>; <xref ref-type="fig" rid="F3">Fig 3C</xref>) than the virus-free groups. When analysing growth in the virus-inoculated groups, mass was significantly higher in embryos that were treated with ClO<sub>2</sub> (t = -2.74, df = 12.98, p = 0.017). Body length of virus-inoculated chicks did not vary according to ClO<sub>2</sub> treatment (p &gt; 0.1). See <xref ref-type="supplementary-material" rid="SD1">supplementary material</xref> for photographs of the embryos.</p>
<p id="P10">Lesions previously described in embryos infected with avian coronavirus were observed at post mortem examination. Namely, curling, the presence of white caseous material (urates), thickened amnion and allantoic membranes that adhered to the embryos, oedematous serous membranes, epidermal congestion, and subcutaneous haemorrhage (<xref ref-type="table" rid="T2">Table 2</xref>). Virus-inoculated embryos treated with ClO<sub>2</sub> had a lower risk of epidermal congestion (RR = 0.4; Wald 95% CI: 0.187-0.855; p = 0.04), haemorrhage (RR = 0.1; Wald 95% CI: 0.016 - 0.642; p = 0.002), curling (RR = 0.019; Wald 95% CI: 0.125 - 0.844; p = 0.017) and thickened membranes (RR = 0; p = 0.003) than untreated infected embryos. All the embryos had a pale liver and mildly congested lungs, regardless of their experimental group. Pale enlarged kidneys were observed in the virus-inoculated groups but not in the virus-free groups, regardless of ClO<sub>2</sub>-treatment (see <xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p id="P11">Microscopic lesions compatible with avian IBV infection were observed in various organs in all virus-inoculated groups (<xref ref-type="fig" rid="F4">Fig. 4</xref>). The severity of the lesions was either similar or slightly lower in the embryos that had been treated with ClO<sub>2</sub> than in the embryos that did not receive any treatment (<xref ref-type="table" rid="T3">Table 3</xref>). Two exceptions were the kidneys and the duodenum. In the kidneys, swelling and degeneration of renal tubular epithelium was more common and more severe in the infected chicks that were administered ClO<sub>2</sub> than in the infected embryos that did not receive ClO<sub>2</sub>, although the former presented mitotic cells. The duodenal villi of the embryos in the IBV-infected groups were longer (ANOVA; F<sub>5,18</sub> = 5.62, p = 0.003), and their base was wider (ANOVA; F<sub>5,18</sub> = 13.65, p = 1.39 x 10<sup>-05</sup>) than embryos from the none-infected groups, and they were moderately congested. Duodenal villous atrophy varied amongst groups (ANOVA; F<sub>5,18</sub> = 5.71, p = 0.003) and <italic>post-hoc</italic> comparisons revealed that the significant differences were E <italic>vs.</italic> B (p = 0.021) and E <italic>vs.</italic> C (p = 0.001). The percent of bursal lymphoid tissue decreased markedly in the virus-inoculated embryos (ANOVA; F<sub>5,12</sub> = 3.58, p = 0.033; see <xref ref-type="fig" rid="F4">Fig. 4</xref>). Virus-inoculated embryos showed mild apoptosis in the thymus and heterophilic infiltration. Amongst the six experimental groups, all of the embryos examined presented subacute heterophilic bursitis, and pulmonary interstitial multifocal heterophilic foci with congestion (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p id="P12">There were no observable alterations to the architecture and integrity of the tissues of non-infected embryos that were administered ClO<sub>2</sub> (Experimental groups B and C), nor was any difference in the area (μm<sup>2</sup>) of the thyroid (p&gt;0.1). ClO<sub>2</sub>-treated groups showed a slightly higher myeloid to erythroid ratio in the bone marrow than the experimental control group and the viral control group, although the difference was not statistically significant (ANOVA; F<sub>5,15</sub> = 2.33, p = 0.094).</p>
</sec>
<sec id="S6" sec-type="discussion">
<title>Discussion</title>
<p id="P13">We have investigated the antiviral effect of chlorine dioxide (ClO<sub>2</sub>) using avian infectious bronchitis coronavirus (IBV)-infected chick embryos as models. At the concentrations used (30 ppm and 300 ppm), both below the reported NOAEL [<xref ref-type="bibr" rid="R13">13</xref>], we observed a reduction in viral titre in infected embryos that were treated with ClO<sub>2</sub>. Furthermore, mortality decreased substantially in the ClO<sub>2</sub>-treated embryos, although alterations to chick development were prevalent regardless of treatment.</p>
<p id="P14">Virulent avian IBV strains typically have a burst size of 10 to 100 infective units per cell [<xref ref-type="bibr" rid="R28">28</xref>], which can reach peak virus titres of 10<sup>6.5</sup>–10<sup>8.5</sup> TCID<sub>50</sub> after 36 hours [<xref ref-type="bibr" rid="R29">29</xref>]. The vaccine strains used here have lower replication efficiencies as they are attenuated [<xref ref-type="bibr" rid="R30">30</xref>], but they are capable of replicating and causing damage in chick embryos [<xref ref-type="bibr" rid="R27">27</xref>]. With 2,000 infective units (200 μl of 10<sup>4</sup> infective units/mL) inoculated into each embryo, the ClO<sub>2</sub> treatments decreased viral load 2.4-fold compared to the infected non-treated embryos, representing an average difference of 42,711 infective units. This result could be explained by two non-mutually exclusive mechanisms. Firstly, direct destruction or neutralization of the virions exposed to ClO<sub>2</sub> could have occurred by denaturing of envelope glycoproteins following oxidation of amino acid residues [<xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R25">25</xref>]. Secondly, viral replication efficiency could have decreased due to ClO<sub>2</sub>–induced biochemical changes in the extra- or intracellular milieu, impeding the synthesis of viral RNA and proteins [<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R31">31</xref>].</p>
<p id="P15">The effects of reduced viral titres in the infected embryos were evident, with a 50 to 75% reduction in mortality in the treated embryos treated with 300 ppm and 30 ppm of ClO<sub>2</sub>, respectively. However, developmental abnormalities were observed in the majority of the infected embryos, including those that received ClO<sub>2</sub> treatment. Namely, dwarfing, assessed by body mass, axis length, and femur length were significantly lower in all infected embryos, as expected to occur in IBV infections [<xref ref-type="bibr" rid="R32">32</xref>]. In contrast, curling [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R34">34</xref>] was virtually absent in the embryos that received ClO<sub>2</sub> after infection. Lesions associated con IBV infection [<xref ref-type="bibr" rid="R35">35</xref>, <xref ref-type="bibr" rid="R36">36</xref>] were observed in most of the infected embryos, including those that were administered ClO<sub>2</sub>. However, for most of these lesions, severity was lower or similar in the ClO<sub>2</sub>-treated groups. One exception was in the kidneys, where nephrosis was more severe and frequent in the IBV-infected embryos treated with ClO<sub>2</sub>. Nephrosis is unlikely to have occurred due to ClO<sub>2</sub> treatment <italic>per se</italic>, given that none of the uninfected embryos that were administered ClO<sub>2</sub> showed kidney abnormalities. Similarly, atrophy of the duodenal villi was highest in the inoculated group that was administered a high dose of ClO<sub>2</sub>, but absent in the non-infected groups that only received ClO<sub>2</sub>. If duodenal atrophy and nephropathogenicity in IBV-infected embryos are mitigated by inflammatory responses [<xref ref-type="bibr" rid="R37">37</xref>], it is possible that the observed damage is due to ClO<sub>2</sub>-driven downregulation of acute inflammation that allowed virion replication in the tubular epithelium and in the duodenal villi. This scenario could be plausible if we consider that ClO<sub>2</sub>-treated pig alveolar macrophages and African green monkey kidney cells infected with the porcine reproductive and respiratory syndrome virus (PRRSV1) downregulate pro-inflammatory cytokines IL-1, IL-6 and TNF-α [<xref ref-type="bibr" rid="R26">26</xref>]. There are two drugs, based on chlorite, whose describe mechanism of action might be similar to that elicited by ClO<sub>2</sub>. One is the drug NP001 (a pH-adjusted stabilized form of NaClO<sub>2</sub>) exerts strong anti-inflammatory responses by inhibiting macrophage activation in humans, even after a single dose [<xref ref-type="bibr" rid="R38">38</xref>]. In turn, WF10 (tetrachlorodecaoxyde, Cl<sub>4</sub>H<sub>2</sub>O<sub>11</sub>), an oxidizing agent that contains 63.0 mmol/L chlorite and 56.4 mmol/L chloride [<xref ref-type="bibr" rid="R39">39</xref>] induces apoptosis of inflammatory cells and downregulates pro-inflammatory genes [<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R41">41</xref>]. More studies will be needed to establish whether the effect of ClO<sub>2</sub> on IBV-infected chicks is due to similar mechanisms. Interestingly, the affected renal tubules of the chick embryos had mitotic cells, suggestive of regeneration as a reparative response to damage of the renal tubular epithelium [<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R44">44</xref>]. This possibility will need to be explored further in the animal model used in our study. Unfortunately, knowledge of IBV pathogenesis, immune responses and tissue reparation in the embryonated egg is limited. In hatched birds, IBV can impact lymphocyte populations by inducing apoptosis, thus impeding virus clearance [<xref ref-type="bibr" rid="R45">45</xref>]. We found some evidence of this effect, as the virus-inoculated embryos had a reduced percent of bursal lymphoid tissue.</p>
<p id="P16">It is plausible that even though ClO<sub>2</sub> limited viral replication, given that the embryos were only administered a single dose of ClO<sub>2</sub> solution, not all virions were eliminated. The viruses that remained viable after administration of the ClO<sub>2</sub> were able to replicate, yielding lower viral titres, and the damage that they caused to the embryos was less severe and ultimately led to less mortality than in the untreated infected embryos. Repeated administrations of ClO<sub>2</sub> solution might have reduced the viral load further, plausibly leading to even less virus-induced damage, a possibility that we could not explore in this model. However, an important result of our study was the lack of evidence of tissue damage caused by ClO<sub>2</sub> itself. Only one (20%) of the uninfected embryos treated with the high dose of ClO<sub>2</sub> died, and this difference was not statistically significant to the experimental control. It is possible that the death was due to other causes, as a 20% embryo mortality rate is considered normal in aviculture [<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>].</p>
</sec>
<sec id="S7" sec-type="conclusions">
<title>Conclusions</title>
<p id="P17">Chlorine dioxide had an unequivocal antiviral effect in the model system used in this study, with a reduction in viral RNA, virus-induced lesions and mortality and no evidence of toxicity at the doses used herein. Further studies should aim to test the antiviral effect of ClO<sub>2</sub> in hatched chicks, which have a more mature immune system, and where repeated administrations are easier to procure. However, it is promising that we found an evident effect against IBV without any significant adverse effect or evidence of toxicity to the chick embryos. Much research needs to be done before it is possible to generalize and extrapolate our findings to other viruses and animal hosts.</p>
</sec>
<sec id="S8" sec-type="methods">
<title>Methods</title>
<p id="P18">We aimed to examine whether chlorine dioxide elicits a measurable antiviral effect <italic>in vivo</italic>, and investigate toxicity associated with the administration of this chemical compound. For this, we selected the chicken embryo as a vertebrate model and avian infectious bronchitis coronavirus (IBV) as a virus model. The protocol that is described below was registered at the School of Natural Sciences of the Autonomous University of Queretaro (Mexico). The study was carried out in compliance with the American Veterinary Medical Association (AVMA) guide for humane treatment of chick embryos and approved by the Autonomous University of Queretaro Research Ethics Committee</p>
<p id="P19">Ultrapure ClO<sub>2</sub> solution (3,000 ppm) was prepared by electrolysis of NaClO<sub>2</sub>, according to the following reaction: <disp-formula id="FD1">
<mml:math id="M1">
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>l</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>+</mml:mo>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>O</mml:mi>
<mml:mo>+</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mo>−</mml:mo>
</mml:msup>
<mml:mo>→</mml:mo>
<mml:mi>C</mml:mi>
<mml:mi>l</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>g</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo>+</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>2</mml:mn>
</mml:mfrac>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>g</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p id="P20">The solution was kept at 4 °C and was used within 5 days of production. Two working solutions were prepared with sterile 0.9% saline solution: a high dose (HD, 300 ppm) and a low dose (LD, 30 ppm). Final concentration was verified using test strips (LaMotte Insta-Test 3002) which allowed qualitative detection between 0 and 500 ppm.</p>
<p id="P21">We used 30 10-day old SPF RossxRoss chick embryos (Pilgrims, Mexico) incubated at 38°C and 65-70% humidity [<xref ref-type="bibr" rid="R48">48</xref>]. Five chick embryos were assigned to each of the six experimental groups at random and treated according to their group (<xref ref-type="table" rid="T1">Table 1</xref>). Total sample size in the experimental group was determined in order to achieve power 80% (type II error: 0.20) with allocation ratio 2/1, effect size of 0.7 and a significance level &lt; 0.05. Embryos were placed at random in the incubator to avoid potential variations in temperature and humidity between the edges and the centre of the incubator. All embryos were inoculated via the chorioallanotic sac, as recommended for avian coronavirus replication [<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R50">50</xref>]. Details on inoculation can be seen as <xref ref-type="supplementary-material" rid="SD1">Supplementary Materials</xref>.</p>
<p id="P22">Seven days after inoculation, embryos were sacrificed according to guidelines on humane treatment and euthanasia of chick embryos over 13 days of age (AVMA 2020). The embryos were placed at 4 °C for 4 h to ensure blood coagulation and avoid contamination of the allantoic fluid [<xref ref-type="bibr" rid="R48">48</xref>]. The eggshell over the air chamber was disinfected with 70% ethanol and 3.5% iodine [<xref ref-type="bibr" rid="R48">48</xref>] and removed together with the chorioallantoic membrane. Allanotic fluid (750 μl) was collected and stored at −70 °C.</p>
<p id="P23">Each embryo was cleaned with distilled water to remove any remaining albumin, vitellus and amniotic fluid. Body mass was determined with a precision scale (±0.1 mg). Embryonic axis length was measured with digital callipers (± 0.1 cm). The body was examined for macroscopic lesions typically caused by avian coronavirus, such as cutaneous haemorrhages, stunting, curving, urate deposits in the kidney and feather alterations [<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R51">51</xref>]. Chick embryos were considered to have died during the experiment when there was evidence of disconnected or detached blood vessels of the chorioallantoic membrane or their organs exhibited imbibition of haemoglobin. Further evidence of mortality was determined by examining the presence of autolysis at microscopic examination.</p>
<p id="P24">Both femurs were dissected and their length was determined and averaged with a digital calliper as a surrogate measure of chick development. Samples of all organs and tissues were collected, including those known to be affected by the Massachusetts and Connecticut strains of avian coronavirus, namely trachea, lung, proventricle, duodenum, liver, kidneys and the Bursa of Fabricius [<xref ref-type="bibr" rid="R27">27</xref>, <xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R52">52</xref>, <xref ref-type="bibr" rid="R53">53</xref>], and those reportedly affected by exposure to ClO<sub>2</sub> [<xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R54">54</xref>, <xref ref-type="bibr" rid="R55">55</xref>].</p>
<p id="P25">Samples were cut longitudinally, immersed in 10% buffered formalin (pH 7.4), paraffin-embedded and sectioned at 3 μm, stained with haematoxylin-eosin and observed under the microscope at 40X and 100X. To assess haematopoietic status, bone marrow preparations were used for a 200-cell differential count to classify the marrow precursors and to determine the myeloid:erythroid (M/E) ratio for each embryo. This ratio was obtained by dividing the sum of all the granulocytic cells by the sum of all the erythrocytic cells [<xref ref-type="bibr" rid="R56">56</xref>].</p>
<p id="P26">The virus was quantified in the allantoid fluid with an RT-qPCR protocol that targeted a 100 bp fragment of the avian coronavirus N gene with primers IBV-pan_FW-1 (5′-CAG TCC CDG ATG CNT GGT A) and IBV-pan_RV (5′-CC TTW SCA GMA ACM CAC ACT)[<xref ref-type="bibr" rid="R57">57</xref>]. Details on the protocol can be seen as <xref ref-type="supplementary-material" rid="SD1">Supplementary Materials</xref>. We used a cDNA sample extracted from 500 μL of the vaccine as a positive control (the vaccine contained 10<sup>4</sup> mean embryo infective dose (EID<sub>50</sub>)/mL of coronavirus strains Massachusetts and Connecticut). A linear regression was used to calculate the correlation coefficient (R<sup>2</sup> = 0.99) and the slope value (b = -5.062) of the RNA copy number and Cq values using a 10-fold dilution of the vaccine (10<sup>4</sup> to 10<sup>-1</sup>; see standard curve in <xref ref-type="supplementary-material" rid="SD1">Supplementary material</xref>). The number of viral RNA copies (hereafter viral load) was determined by comparing the Cq against this standard curve [<xref ref-type="bibr" rid="R57">57</xref>].</p>
<p id="P27">Contingency tables were built to investigate differences in the proportion of dead <italic>vs</italic>. live chick embryos between experimental groups. The risk of developing virus-related lesions between treated and un-treated embryos was calculated using Fisher exact tests. Body mass, morphometrics, viral load, and lesion severity were compared among groups by one-way ANOVA and post-hoc Tukey HSD tests. All analyses were performed in R version 3.6.3 [<xref ref-type="bibr" rid="R58">58</xref>].</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary material</label>
<media xlink:href="EMS103447-supplement-Supplementary_material.pdf" mimetype="application" mime-subtype="pdf" id="N66693" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S9">
<title>Acknowledgments</title>
<p>We thank Luis A. Soto-García and Karla Zamora y Cuevas for their help with photographic and video documentation of the experiment.</p>
<sec id="S10">
<title>Funding</title>
<p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p>
</sec>
</ack>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P28">
<bold>Statement of conflict of interest</bold>
</p>
<p id="P29">The authors declare they do not have any conflict of interest regarding this submission.</p>
</fn>
<fn id="FN2" fn-type="con">
<p id="P30">
<bold>Author contributions</bold>
</p>
<p id="P31">K.A-W. and T.G-G. conceived the idea. K.A-W. supervised the experiments and wrote the manuscript. X.Z-E. performed all gross examinations and histopathology analyses. C.D-S. conducted molecular assays and artwork. M.B-M. and F.G-D performed the inoculation experiments and assisted during necropsies. K.A-W. and L.P-V conducted the statistical analyses. All authors participated in the discussion of results.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Coronavirus: limit short-term economic damage</article-title>
<source>Nature</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alsafi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sohrabi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kerwan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Jabir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iosifidis</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>The socio-economic implications of the coronavirus pandemic (COVID-19): A review</article-title>
<source>International Journal of Surgery</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigstam</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rohatschek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Brennecke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>On the cause of the tailing phenomenon during virus disinfection by chlorine dioxide</article-title>
<source>Water Res</source>
<year>2014</year>
<volume>48</volume>
<fpage>82</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Gálvez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Randazzo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Vásquez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sánchez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Decol</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Aznar</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Irrigating Lettuce with Wastewater Effluent: Does Disinfection with Chlorine Dioxide Inactivate Viruses?</article-title>
<source>J Environ Qual</source>
<year>2018</year>
<volume>47</volume>
<fpage>1139</fpage>
<lpage>45</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doona</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Feeherry</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Setlow</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Malkin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Leighton</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>The Portable Chemical Sterilizer (PCS), D-FENS, and D-FEND ALL: novel chlorine dioxide decontamination technologies for the military</article-title>
<source>J Vis Exp</source>
<year>2014</year>
<fpage>e4354</fpage>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loh</surname>
<given-names>JMR</given-names>
</name>
<name>
<surname>Shafi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Kikuchi-Fujimoto disease presenting after consumption of “Miracle Mineral Solution” (sodium chlorite)</article-title>
<source>BMJ Case Rep</source>
<year>2014</year>
<volume>2014</volume>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bathina</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yadla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Burri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Enganti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>Ch R</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>An unusual case of reversible acute kidney injury due to chlorine dioxide poisoning</article-title>
<source>Ren Fail</source>
<year>2013</year>
<volume>35</volume>
<fpage>1176</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romanovsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Djogovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>A case of sodium chlorite toxicity managed with concurrent renal replacement therapy and red cell exchange</article-title>
<source>J Med Toxicol Off J Am Coll Med Toxicol</source>
<year>2013</year>
<volume>9</volume>
<fpage>67</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishan</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Chlorine dioxide-induced acute hemolysis</article-title>
<source>Journal of medical toxicology : official journal of the American College of Medical Toxicology</source>
<year>2009</year>
<volume>5</volume>
<fpage>177</fpage>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lubbers</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chauan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bianchine</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man</article-title>
<source>Environ Health Perspect</source>
<year>1982</year>
<volume>46</volume>
<fpage>57</fpage>
<lpage>62</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akamatsu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Morino</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ogata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Six-month low level chlorine dioxide gas inhalation toxicity study with two-week recovery period in rats</article-title>
<source>J Occup Med Toxicol</source>
<year>2012</year>
<volume>7</volume>
<fpage>2</fpage>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J-W</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B-S</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>C-W</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C-W</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>M-L</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>J-Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Efficacy and Safety Evaluation of a Chlorine Dioxide Solution</article-title>
<source>Int J Environ Res Public Health</source>
<year>2017</year>
<volume>14</volume>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercz</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Boston</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Subchronic toxicity of chlorine dioxide and related compounds in drinking water in the nonhuman primate</article-title>
<source>Environ Health Perspect</source>
<year>1982</year>
<volume>46</volume>
<fpage>47</fpage>
<lpage>55</lpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hose</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Di Fiore</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Sciarrotta</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Toxicity of chlorine dioxide to early life stages of marine organisms</article-title>
<source>Bull Environ Contam Toxicol</source>
<year>1989</year>
<volume>42</volume>
<fpage>315</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Carratalà</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ossola</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bachmann</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cross-Resistance of UV- or Chlorine Dioxide-Resistant Echovirus 11 to Other Disinfectants</article-title>
<source>Front Microbiol</source>
<year>2017</year>
<volume>8</volume>
<fpage>1928</fpage>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Chlorine dioxide inactivation of enterovirus 71 in water and its impact on genomic targets</article-title>
<source>Environ Sci Technol</source>
<year>2013</year>
<volume>47</volume>
<fpage>4590</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonet</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gantzer</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Degradation of the Poliovirus 1 genome by chlorine dioxide</article-title>
<source>J Appl Microbiol</source>
<year>2006</year>
<volume>100</volume>
<fpage>862</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Vaughn</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Inactivation of human and simian rotaviruses by chlorine dioxide</article-title>
<source>Appl Environ Microbiol</source>
<year>1990</year>
<volume>56</volume>
<fpage>1363</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montazeri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Manuel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Moorman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Khatiwada</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Jaykus</surname>
<given-names>L-A</given-names>
</name>
</person-group>
<article-title>Virucidal Activity of Fogged Chlorine Dioxide- and Hydrogen Peroxide-Based Disinfectants against Human Norovirus and Its Surrogate, Feline Calicivirus, on Hard-to-Reach Surfaces</article-title>
<source>Front Microbiol</source>
<year>2017</year>
<volume>8</volume>
<fpage>1031</fpage>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Disinfection kinetics of murine norovirus using chlorine and chlorine dioxide</article-title>
<source>Water Res</source>
<year>2010</year>
<volume>44</volume>
<fpage>3243</fpage>
<lpage>51</lpage>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X-W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J-S</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Q-X</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>
<article-title>Study on the resistance of severe acute respiratory syndrome-associated coronavirus</article-title>
<source>J Virol Methods</source>
<year>2005</year>
<volume>126</volume>
<fpage>171</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Protective effect of low-concentration chlorine dioxide gas against influenza A virus infection</article-title>
<source>J Gen Virol</source>
<year>2008</year>
<volume>89</volume>
<issue>1</issue>
<fpage>60</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ison</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Odeh</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Margerum</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Kinetics and mechanisms of chlorine dioxide and chlorite oxidations of cysteine and glutathione</article-title>
<source>Inorg Chem</source>
<year>2006</year>
<volume>45</volume>
<fpage>8768</fpage>
<lpage>75</lpage>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Napolitano</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bakhmutova-Albert</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Margerum</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Kinetics and mechanisms of chlorine dioxide oxidation of tryptophan</article-title>
<source>Inorg Chem</source>
<year>2008</year>
<volume>47</volume>
<fpage>1639</fpage>
<lpage>47</lpage>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noss</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Olivieri</surname>
<given-names>VP</given-names>
</name>
</person-group>
<article-title>Disinfecting capabilities of oxychlorine compounds</article-title>
<source>Appl Environ Microbiol</source>
<year>1985</year>
<volume>50</volume>
<fpage>1162</fpage>
<lpage>4</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Chlorine dioxide inhibits the replication of porcine reproductive and respiratory syndrome virus by blocking viral attachment</article-title>
<source>Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis</source>
<year>2019</year>
<volume>67</volume>
<fpage>78</fpage>
<lpage>87</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>C-T</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H-F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C-H</given-names>
</name>
</person-group>
<article-title>Detection of infectious bronchitis virus strains similar to Japan in Taiwan</article-title>
<source>J Vet Med Sci</source>
<year>2016</year>
<volume>78</volume>
<fpage>867</fpage>
<lpage>71</lpage>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Robb</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bond</surname>
<given-names>CW</given-names>
</name>
</person-group>
<chapter-title>Coronaviridae</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Fraenkel-Conrat</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>RR</given-names>
</name>
</person-group>
<source>Comprehensive Virology</source>
<publisher-loc>Boston</publisher-loc>
<publisher-name>Springer</publisher-name>
<year>1979</year>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otsuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Noro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsubokura</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Studies on avian infectious bronchitis virus (IBV). II. Propagation of IBV in several cultured cells</article-title>
<source>Arch Virol</source>
<year>1979</year>
<volume>60</volume>
<fpage>115</fpage>
<lpage>22</lpage>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>C-T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H-Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C-H</given-names>
</name>
</person-group>
<article-title>Genetic sequence changes related to the attenuation of avian infectious bronchitis virus strain TW2575/98</article-title>
<source>Virus Genes</source>
<year>2020</year>
<volume>56</volume>
<fpage>369</fpage>
<lpage>79</lpage>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enjuanes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Almazán</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sola</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Zuñiga</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Biochemical aspects of coronavirus replication and virus-host interaction</article-title>
<source>Annu Rev Microbiol</source>
<year>2006</year>
<volume>60</volume>
<fpage>211</fpage>
<lpage>30</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasubramaniam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sukumar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Puvarajan</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Molecular characterisation of membrane glycoprotein and 5b protein of nephropathogenic infectious bronchitis virus</article-title>
<source>Vet World</source>
<year>2013</year>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickramasinghe</surname>
<given-names>INA</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Gröne</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Haan</surname>
<given-names>CAM</given-names>
</name>
<name>
<surname>Verheije</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity</article-title>
<source>J Virol</source>
<year>2011</year>
<volume>85</volume>
<fpage>8903</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mork</surname>
<given-names>A-K</given-names>
</name>
<name>
<surname>Hesse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abd El Rahman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rautenschlein</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Differences in the tissue tropism to chicken oviduct epithelial cells between avian coronavirus IBV strains QX and B1648 are not related to the sialic acid binding properties of their spike proteins</article-title>
<source>Vet Res</source>
<year>2014</year>
<volume>45</volume>
<fpage>67</fpage>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butcher</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Winterfield</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Pathogenesis of H13 nephropathogenic infectious bronchitis virus</article-title>
<source>Avian Dis</source>
<year>1990</year>
<volume>34</volume>
<fpage>916</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>JKA</given-names>
</name>
<name>
<surname>Jackwood</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>The long view: 40 years of infectious bronchitis research</article-title>
<source>Avian Pathol</source>
<year>2012</year>
<volume>41</volume>
<fpage>239</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chhabra</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chantrey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ganapathy</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Differential innate immune responses induced by classical and variant infectious bronchitis viruses in specific pathogen free chicks</article-title>
<source>Dev Comp Immunol</source>
<year>2018</year>
<volume>87</volume>
<fpage>16</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barohn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kasarskis</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study</article-title>
<source>Amyotroph Lateral Scler Frontotemporal Degener</source>
<year>2014</year>
<volume>15</volume>
<fpage>601</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veerasarn</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Khorprasert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lorvidhaya</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sangruchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tantivatana</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Narkwong</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: a multicenter, randomized, two-arm, open-label trial</article-title>
<source>Radiother Oncol J Eur Soc Ther Radiol Oncol</source>
<year>2004</year>
<volume>73</volume>
<fpage>179</fpage>
<lpage>85</lpage>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giese</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Stumm</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schempp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Elstner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Meuer</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Differential effects on innate versus adaptive immune responses by WF10</article-title>
<source>Cell Immunol</source>
<year>2004</year>
<volume>229</volume>
<fpage>149</fpage>
<lpage>58</lpage>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yingsakmongkol</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maraprygsavan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sukosit</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial</article-title>
<source>J foot ankle Surg Off Publ Am Coll Foot Ankle Surg</source>
<year>2011</year>
<volume>50</volume>
<fpage>635</fpage>
<lpage>40</lpage>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujigaki</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Different modes of renal proximal tubule regeneration in health and disease</article-title>
<source>World J Nephrol</source>
<year>2012</year>
<volume>1</volume>
<fpage>92</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lombardi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Becherucci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Romagnani</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>How much can the tubule regenerate and who does it? An open question</article-title>
<source>Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc</source>
<year>2016</year>
<volume>31</volume>
<fpage>1243</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toback</surname>
<given-names>FG</given-names>
</name>
</person-group>
<article-title>Regeneration after acute tubular necrosis</article-title>
<source>Kidney Int</source>
<year>1992</year>
<volume>41</volume>
<fpage>226</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caron</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>Etiology and immunology of infectious bronchitis virus</article-title>
<source>Rev Bras Cienc Avic</source>
<year>2010</year>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Romanoff</surname>
<given-names>AL</given-names>
</name>
</person-group>
<chapter-title>Spontaneous malformations</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Romanoff</surname>
<given-names>AL</given-names>
</name>
</person-group>
<source>Pathogenesis of the avian embryo: an analysis of causes of malformations and prenatal death</source>
<publisher-loc>New York</publisher-loc>
<publisher-name>Wiley Interscience</publisher-name>
<year>1972</year>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasenko</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>O’Dea</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Evaluating broiler growth and mortality in chicks with minor navel conditions at hatching</article-title>
<source>Poult Sci</source>
<year>2008</year>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guy</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Isolation and propagation of coronaviruses in embryonated eggs</article-title>
<source>Methods Mol Biol</source>
<year>2015</year>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escorcia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fortoul</surname>
<given-names>TI</given-names>
</name>
<name>
<surname>Petrone</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Galindo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>López</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Téllez</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Gastric gross and microscopic lesions caused by the UNAM-97 variant strain of infectious bronchitis virus after the eighth passage in specific pathogen-free chicken embryos</article-title>
<source>Poult Sci</source>
<year>2002</year>
<volume>81</volume>
<fpage>1647</fpage>
<lpage>52</lpage>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jordan</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>The combined influence of age of embryo and temperature and duration of incubation on the replication and yield of avian infectious bronchitis (IB) virus in the developing chick embryo</article-title>
<source>Avian Pathol</source>
<year>1973</year>
<volume>2</volume>
<fpage>279</fpage>
<lpage>94</lpage>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="other">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Senne</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>A Laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens</article-title>
<year>2008</year>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavanagh</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus</article-title>
<source>Avian Pathol</source>
<year>2003</year>
<volume>32</volume>
<fpage>567</fpage>
<lpage>82</lpage>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavanagh</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Coronavirus avian infectious bronchitis virus</article-title>
<source>Vet Res</source>
<year>2007</year>
<volume>38</volume>
<fpage>281</fpage>
<lpage>97</lpage>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrington</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Shertzer</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Bercz</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Effects of chlorine dioxide on thyroid function in the African green monkey and the rat</article-title>
<source>J Toxicol Environ Health</source>
<year>1986</year>
<volume>19</volume>
<fpage>235</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="book">
<collab>Environmental Protection Agency</collab>
<source>Toxicological Review of Chlorine dioxide and Chlorite</source>
<publisher-loc>Washington, D.C.</publisher-loc>
<year>2000</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://www.epa.gov/iris">http://www.epa.gov/iris</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Schalm</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>NC</given-names>
</name>
</person-group>
<source>Schalm’s veterinary hematology</source>
<edition>4th editio</edition>
<publisher-loc>Philadelphia</publisher-loc>
<publisher-name>Lea &amp; Febiger</publisher-name>
<year>1986</year>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naguib</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>El-Kady</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Lüschow</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Arafa</surname>
<given-names>A-S</given-names>
</name>
<name>
<surname>El-Zanaty</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle Disease viruses</article-title>
<source>J Virol Methods</source>
<year>2017</year>
<volume>245</volume>
<fpage>19</fpage>
<lpage>27</lpage>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="book">
<collab>R Core Team</collab>
<article-title>R Development Core Team</article-title>
<publisher-name>R A Lang Environ Stat Comput</publisher-name>
<year>2016</year>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<boxed-text id="BX1" position="float" orientation="portrait">
<caption>
<title>Highlights</title>
</caption>
<list list-type="bullet" id="L1">
<list-item>
<p id="P32">Chlorine dioxide (ClO<sub>2</sub>) reduces mortality in chick embryos inoculated with avian infectious bronchitis coronavirus.</p>
</list-item>
<list-item>
<p id="P33">Viral RNA was 2.4-fold lower in the embryos that were treated with ClO<sub>2</sub>.</p>
</list-item>
<list-item>
<p id="P34">Microscopic lesions were less severe in ClO<sub>2</sub>-treated embryos.</p>
</list-item>
<list-item>
<p id="P35">There was no evidence of toxicity caused by ClO<sub>2</sub> at the doses used.</p>
</list-item>
</list>
</boxed-text>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Virus RNA copy number in the allantoic fluid of the infected embryos per treatment group. Virus copy number was calculated by the geometric mean of the triplicate Cq value referred to the standard curve (see <xref ref-type="sec" rid="S8">methods</xref>). Experimental groups D to F contained virus-inoculated embryos (D: Low dose of ClO<sub>2</sub>, E: High dose of ClO<sub>2</sub>, F. Viral control). For details on treatments, see <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="EMS103447-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Chick embryo mortality during the experiment. Experimental groups A to C contained virus-free embryos (A: Experimental control, B: Low dose of ClO<sub>2</sub>, C: High dose of ClO<sub>2</sub>); experimental groups D to F contained virus-inoculated embryos (D: Low dose of ClO<sub>2</sub>, E: High dose of ClO<sub>2</sub>, F. Viral control). For details on treatments, see <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="EMS103447-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Chick embryo development at the end of the experiment (day 17 of incubation). A) mass, B) body axis, C) femur length. Experimental groups A to C contained virus-free embryos (A: Experimental control, B: Low dose of ClO<sub>2</sub>, C: High dose of ClO<sub>2</sub>); experimental groups D to F contained virus-inoculated embryos (D: Low dose of ClO<sub>2</sub>, E: High dose of ClO<sub>2</sub>, F. Viral control). For details on treatments, see <xref ref-type="table" rid="T1">Table 1</xref>.</p>
</caption>
<graphic xlink:href="EMS103447-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Histology of selected tissues from 17-day-old chick embryos. In each row, microphotograph pairs show H&amp;E-stained representative tissues of non-infected (left) and infected embryos (right), A) Bursa of Fabricio (100X). Infected embryos showed severe lymphoid depletion, with approximately 10% of active lymphoid tissue and abundant heterophils. B) Bone marrow (400 X). Infected embryos showed an increase in erythroid cellularity ne, C) Spleen (400 X), Infected embryos showed reticuloendothelial hyperplasia, D) Duodenum (400 X). Infected embryos showed mild villous atrophy, E) Proventricle (40X). Infected embryos showed epithelial hyperplasia with desquamation and hyaline material, F) Proventricle (400X). Image shows the increased length of the proventricular folds and mitotic cells indicative of epithelial regeneration, G) Kidney (400X). Infected embryos showed swelling, cell detritus and protein within the tubules, and basophilic material compatible with urate crystals, H) Liver (400X). Infected embryos showed glucogenic degeneration, I) Trachea (400X). Infected embryos showed hyperplasia and epithelial degeneration. Scale = 50 μm in all panels except for E (scale = 500 μm).</p>
</caption>
<graphic xlink:href="EMS103447-f004"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Experimental groups used to assess the <italic>in vivo</italic> antiviral effect of high and low concentrations of ClO<sub>2</sub> solution in chick embryos. The table shows the number of embryos included in each group. (LD: Low dose, HD: High dose)</title>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center">Group</th>
<th valign="top" align="center">N</th>
<th valign="top" align="center">Treatment</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Group A (Experimental control)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">200 μl of sterile 0.9% saline solution</td>
</tr>
<tr>
<td valign="top" align="left">Group B (ClO<sub>2</sub> LD)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">100 μl of sterile ClO<sub>2</sub> solution (30 ppm<sup>
<xref ref-type="table-fn" rid="TFN1">1</xref>
</sup>) and 100 μl of sterile 0.9% saline solution</td>
</tr>
<tr>
<td valign="top" align="left">Group C (ClO<sub>2</sub> HD)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">100 μl of sterile ClO<sub>2</sub> solution (300 ppm<sup>
<xref ref-type="table-fn" rid="TFN2">2</xref>
</sup>) and 100 μl of sterile 0.9% saline solution</td>
</tr>
<tr>
<td valign="top" align="left">Group D (Virus + ClO<sub>2</sub> LD)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">100 μl of resuspended avian coronavirus vaccine and 100 μl of sterile ClO<sub>2</sub> solution (30 ppm)</td>
</tr>
<tr>
<td valign="top" align="left">Group E (Virus + ClO<sub>2</sub> HD)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">100 μl of resuspended avian coronavirus vaccine and 100 μl of sterile ClO<sub>2</sub> solution (300 ppm)</td>
</tr>
<tr>
<td valign="top" align="left">Group F (Viral control)</td>
<td valign="top" align="center">5</td>
<td valign="top" align="left">100 μl of resuspended live attenuated avian coronavirus vaccine (Bron Blen® Merial, containing 10<sup>4</sup> of mean embryo infective dose (EID<sub>50</sub>)/mL of coronavirus strains Massachusetts and Connecticut) and 100 μl of sterile 0.9% saline solution</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<label>1</label>
<p id="P36">This concentration is 10 times below the no-observed-adverse-effect level (NOAEL; 3.5 mg/kg per day) determined for ClO<sub>2</sub> (Bercz et al. 1982), considering an embryonic mass of 10 g at the time of inoculation.</p>
</fn>
<fn id="TFN2">
<label>2</label>
<p id="P37">This concentration is equal to the NOAEL considering an embryonic mass of 10 g at the time of inoculation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 2</label>
<caption>
<title>Macroscopic abnormalities observed at necropsy in the chick embryos.</title>
<p id="P38">The table shows the number of embryos in each group that presented each lesion. (LD: Low dose, HD: High dose)</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Dwarfing</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Curling</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">White caseous material</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Thickened membranes</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Oedema</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Epidermal congestion</th>
<th valign="bottom" align="center" style="writing-mode:tb-rl;writing-mode:vertical-rl;">Pale and enlarged kidneys</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-bottom: dotted thin">Group A (Experimental control)</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5</td>
</tr>
<tr>
<td valign="top" align="left">Group B (ClO<sub>2</sub> LD)</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5</td>
</tr>
<tr>
<td valign="top" align="left">Group C (ClO<sub>2</sub> HD)</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">1/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5</td>
<td valign="top" align="center">2/5</td>
<td valign="top" align="center">0/5</td>
</tr>
<tr>
<td valign="top" align="left">Group D (Virus + ClO<sub>2</sub> LD)</td>
<td valign="top" align="center">5/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">1/5</td>
<td valign="top" align="center">1/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center">0/5</td>
<td valign="top" align="center">2/5</td>
<td valign="top" align="center">5/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>,<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" style="border-bottom: dotted thin">Group E (Virus + ClO<sub>2</sub> HD)</td>
<td valign="top" align="center" style="border-bottom: dotted thin">5/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">1/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5<sup>
<xref ref-type="table-fn" rid="TFN4">f</xref>
</sup>
</td>
<td valign="top" align="center" style="border-bottom: dotted thin">0/5</td>
<td valign="top" align="center" style="border-bottom: dotted thin">2/5</td>
<td valign="top" align="center" style="border-bottom: dotted thin">3/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
</tr>
<tr>
<td valign="top" align="left">Group F (Viral control)</td>
<td valign="top" align="center">5/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">4/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">4/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">4/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">1/5</td>
<td valign="top" align="center">5/5<sup>
<xref ref-type="table-fn" rid="TFN3">a</xref>
</sup>
</td>
<td valign="top" align="center">1/5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN3">
<label>a</label>
<p id="P39">: Indicates a significant difference to the experimental control</p>
</fn>
<fn id="TFN4">
<label>f</label>
<p id="P40">: Indicates a significant difference to the viral control</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float" orientation="landscape">
<label>Table 3</label>
<caption>
<title>Microscopic abnormalities related to avian coronavirus infection in the chick embryos.</title>
<p>(LD: Low dose, HD: High dose)</p>
</caption>
<table frame="hsides" rules="rows">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">A</th>
<th valign="top" align="center">B</th>
<th valign="top" align="center">C</th>
<th valign="top" align="center">D</th>
<th valign="top" align="center">E</th>
<th valign="top" align="center">F</th>
</tr>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">(Exp. control)</th>
<th valign="top" align="center">(ClO<sub>2</sub> LD)</th>
<th valign="top" align="center">(ClO<sub>2</sub> HD)</th>
<th valign="top" align="center">(Virus + ClO<sub>2</sub> LD)</th>
<th valign="top" align="center">(Virus + ClO<sub>2</sub> HD)</th>
<th valign="top" align="center">(Viral control)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Trachea</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Mild hyperplasia</td>
<td valign="top" align="center">Mild hyperplasia</td>
<td valign="top" align="center">Karyorexis, focal hyperplasia</td>
<td valign="top" align="center">Moderate congestion</td>
<td valign="top" align="center">Mild hyperplasia</td>
</tr>
<tr>
<td valign="top" align="left">Lung</td>
<td valign="top" align="center">Mild to moderate congestion</td>
<td valign="top" align="center">Moderate congestion, interstitial oedema</td>
<td valign="top" align="center">Mild to moderate congestion, interstitial oedema</td>
<td valign="top" align="center">Moderate to severe congestion, karyolysis</td>
<td valign="top" align="center">Mild to moderate congestion, moderate oedema</td>
<td valign="top" align="center">Mild to moderate congestion, severe to moderate oedema</td>
</tr>
<tr>
<td valign="top" align="left">Proventricle</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Moderate hyperplasia</td>
<td valign="top" align="center">Mild hyperplasia</td>
<td valign="top" align="center">Moderate hyperplasia, mild congestion</td>
</tr>
<tr>
<td valign="top" align="left">Duodenum</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Moderate congestion</td>
<td valign="top" align="center"/>
<td valign="top" align="center">Mild diffuse congestion, atrophy of intestinal villi</td>
</tr>
<tr>
<td valign="top" align="left">Liver</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Gluogenic degeneration, mild congestion</td>
<td valign="top" align="center">Gluogenic degeneration, mild congestion</td>
<td valign="top" align="center">Gluogenic degeneration, moderate congestion, periportal eosinophilic material</td>
</tr>
<tr>
<td valign="top" align="left">Kidneys</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Degeneration w/ regeneration, congestion, mild heterophilic infiltration, urates</td>
<td valign="top" align="center">Degeneration w/ regeneration, congestion, mild heterophilic infiltration, urates</td>
<td valign="top" align="center">Haemorrhage, multifocal heterophilic infiltration, urates</td>
</tr>
<tr>
<td valign="top" align="left">Spleen</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">Reticuloendothelial hyperplasia</td>
<td valign="top" align="center">Reticuloendothelial hyperplasia</td>
<td valign="top" align="center">Reticuloendothelial hyperplasia</td>
</tr>
<tr>
<td valign="top" align="left">Bursa of Fabricius</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
<td valign="top" align="center">Subacute heterophilic bursitis</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
